These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8726181)

  • 1. Chest wall invasive non-small cell lung cancer: patterns of failure and implications for a revised staging system.
    Harpole DH; Healey EA; DeCamp MM; Mentzer SJ; Strauss GM; Sugarbaker DJ
    Ann Surg Oncol; 1996 May; 3(3):261-9. PubMed ID: 8726181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Factors influencing survival and recurrence and potential significance of postoperative radiotherapy and adjuvant chemotherapy for stage ⅢA-N2 non-small cell lung cancer].
    Han W; Song YZ; He M; Li J; Zhang R; Qiao XY
    Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):861-867. PubMed ID: 27998447
    [No Abstract]   [Full Text] [Related]  

  • 3. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
    Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting long-term survival after en-bloc resection of lung cancer invading the chest wall.
    Chapelier A; Fadel E; Macchiarini P; Lenot B; Le Roy Ladurie F; Cerrina J; Dartevelle P
    Eur J Cardiothorac Surg; 2000 Nov; 18(5):513-8. PubMed ID: 11053809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chest wall invasion in non-small cell lung carcinoma: a rationale for en bloc resection.
    Facciolo F; Cardillo G; Lopergolo M; Pallone G; Sera F; Martelli M
    J Thorac Cardiovasc Surg; 2001 Apr; 121(4):649-56. PubMed ID: 11279404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. False-positivity of mediastinal lymph nodes has negative effect on survival in potentially resectable non-small cell lung cancer.
    Iskender I; Kadioglu SZ; Cosgun T; Kapicibasi HO; Sagiroglu G; Kosar A; Kir A
    Eur J Cardiothorac Surg; 2012 Apr; 41(4):874-9. PubMed ID: 22423060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Two patterns of mediastinal lymph node resection for non-small cell lung cancer of stage IIIA: survival analysis of 219 cases].
    Zhang GQ; Han F; Gao SL; A DL; Pang ZL
    Ai Zheng; 2007 May; 26(5):519-23. PubMed ID: 17672944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.
    Lee BE; Redwine J; Foster C; Abella E; Lown T; Lau D; Follette D
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):615-9. PubMed ID: 18329480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node ratio predicts recurrence and survival after R0 resection for non-small cell lung cancer.
    Taylor MD; LaPar DJ; Thomas CJ; Persinger M; Stelow EB; Kozower BD; Lau CL; Jones DR
    Ann Thorac Surg; 2013 Oct; 96(4):1163-1170. PubMed ID: 23998409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of radiologic stage III substage on nonsurgical therapy of non-small cell lung cancer.
    Kreisman H; Lisbona A; Olson L; Propert KJ; Modeas C; Dillman RO; Seagren SL; Green MR
    Cancer; 1993 Sep; 72(5):1588-96. PubMed ID: 8394201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of Practice in Mediastinal Lymph Node Staging for Non-Small Cell Lung Cancer in Canada.
    Turner SR; Seyednejad N; Nasir BS
    Ann Thorac Surg; 2018 Aug; 106(2):428-434. PubMed ID: 29596820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of a Highly Selective Surgical Approach to Oligometastatic Lung Cancer.
    Johnson KK; Rosen JE; Salazar MC; Boffa DJ
    Ann Thorac Surg; 2016 Oct; 102(4):1166-71. PubMed ID: 27344278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival.
    Bueno R; Richards WG; Swanson SJ; Jaklitsch MT; Lukanich JM; Mentzer SJ; Sugarbaker DJ
    Ann Thorac Surg; 2000 Dec; 70(6):1826-31. PubMed ID: 11156079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.
    Li Z; Yu Y; Lu J; Luo Q; Wu C; Liao M; Zheng Y; Ai X; Gu L; Lu S
    J Thorac Oncol; 2009 Jun; 4(6):702-9. PubMed ID: 19404215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk factor analysis of mediastinal lymph node metastasis in non-small cell lung cancer patients and the strategy of mediastinoscopy prior to surgery].
    Wang X; Zheng L; Zhang SY; Xie ZM; Yu H; Su XD; Wang JY; Huang ZF; Yang MT; Rong TH
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):456-9. PubMed ID: 19950559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome predictors for 143 patients with superior sulcus tumors treated by multidisciplinary approach at the University of Texas M. D. Anderson Cancer Center.
    Komaki R; Roth JA; Walsh GL; Putnam JB; Vaporciyan A; Lee JS; Fossella FV; Chasen M; Delclos ME; Cox JD
    Int J Radiat Oncol Biol Phys; 2000 Sep; 48(2):347-54. PubMed ID: 10974447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcervical Extended Mediastinal Lymphadenectomy: Experience From a North American Cancer Center.
    Yendamuri S; Battoo A; Dy G; Chen H; Gomez J; Singh AK; Hennon M; Nwogu CE; Dexter EU; Huang M; Picone A; Demmy TL
    Ann Thorac Surg; 2017 Nov; 104(5):1644-1649. PubMed ID: 28942077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of Failure After Surgery for Non-Small-cell Lung Cancer Invading the Chest Wall.
    Tandberg DJ; Kelsey CR; D'Amico TA; Crawford J; Chino JP; Tong BC; Ready NE; Wright A
    Clin Lung Cancer; 2017 Jul; 18(4):e259-e265. PubMed ID: 27965012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of invasive mediastinal nodal staging versus positron emission tomography staging alone for early-stage non-small cell lung cancer treated with stereotactic body radiation therapy.
    Schonewolf CA; Verma V; Post CM; Berman AT; Frick MA; Vachani A; Lin C; Simone CB
    Lung Cancer; 2018 Mar; 117():53-59. PubMed ID: 28800837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival following resection of clinically occult N2 non small cell lung cancer.
    Dalton R; Keller S
    J Cardiovasc Surg (Torino); 1994 Dec; 35(6 Suppl 1):13-7. PubMed ID: 7775526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.